The Four Supports Study: Family Support Intervention in Intensive Care Units

Physician-Family Communication in Intensive Care Units Clinical Trial

Official title:

A Trial to Improve Surrogate Decision-Making for Critically Ill Older Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01982877
• Other study ID #: 1R01AG045176-01
• Status: Completed
• Phase: N/A
• Start date: January 2014
• Est. completion date: April 19, 2019

Study information

• Verified date: January 2020
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test the effectiveness of a multi-faceted communication intervention for family members of critically ill patients to reduce the family members' long-term symptoms of depression and anxiety.

Description:

One in four elderly Americans die in or shortly after discharge from an intensive care unit. An expanding body of literature documents that physician-family communication and end-of-life care is poor in intensive care units. These deficiencies are associated with high rates of adverse psychological outcomes among surrogates, physician-family conflict, and life support decisions that may be inconsistent with patients' goals and preferences. There is a lack of information on practical, generalizable interventions that effectively improve this important aspect of care for elderly patients and their families.

The primary aim of this study is to evaluate the effectiveness of a multifaceted communication intervention as compared to an educational control to improve psychological outcomes among family members of critically ill patients, using a randomized, controlled trial design.

This randomized controlled trial involves adding a Family Support Specialist (FSS) to the clinical team to provide four types of support to the families of patients with advanced critical illness: emotional support, communication support (between the clinical team and the family), decisional support (education about the role of a surrogate decision maker) and anticipatory grief support.

The overall aim of the study is to improve the long-term psychological outcomes for family members of critically ill patients, to improve the quality of communication and decision-making between physicians and families, and to improve the patient-centeredness of care.

What happens in the study?

Patient is randomized to one of two groups:

1. INTERVENTION GROUP: Family Support Specialist is added to the clinical team to provide emotional support to the family and facilitate frequent communication with the clinical team.

2. CONTROL GROUP: Receives usual care with the addition of two educational sessions provided by the FSS to teach family members about the ICU environment.

What do participants need to do?

Family Members: Interact with the Family Support Specialist daily. Family Support Specialist addresses family needs and ensures that their questions are addressed.

Physicians: Collaborate with the Family Support Specialist to determine how best to support the family as well as attending clinician-family meetings.

Sample size: With a sample size of 300 patients (450 surrogates), the study is well powered to detect small and clinically important differences in the primary outcome measure Hospital Anxiety and Depression Score (HADS).The trial's original sample size of 400 patients (600 surrogates) was chosen to maximize the power to detect differences in a secondary outcome measure (costs) that required a substantially larger sample size than the primary outcome (HADS). Since the original power calculations were conducted, new data were published which indicated that cost analysis in this context will require an even larger sample size based one effect modification from whether the patient lived or died. Therefore, the Data and Safety Monitoring Board recommended revising the sample size to power the trial on the primary outcome (HADS), which required 300 patients (450 surrogates).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 546
• Est. completion date: April 19, 2019
• Est. primary completion date: April 19, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years and older

Eligibility

Patient Inclusion criteria:

1. age =21,

2. lack of decision making capacity as determined by clinical examination by the attending physician,

3. APACHE II score = 22, AND/OR

4. > 40% risk of death in hospital or >40% chance of severe long term functional impairment as judged by the patient's attending physician.

Patient Exclusion Criteria:

1. lack of a surrogate decision maker and

2. impending organ transplantation.

3. decisions regarding care and treatment already made

4. not currently participating in competing research study

5. Discharged prior to enrollment

6. Incarcerated.

Surrogate Inclusion criteria:

1. age = 18 years,

2. self-identify as being involved in surrogate decision-making for the patient, up to a total of four family/surrogates.

3. able to give full informed consent, and

4. able to complete written questionnaires.

Surrogate Exclusion Criteria:

1. age <18 years old,

2. unable to read and understand English, and

3. unable to complete questionnaires due to physical or cognitive limitations.

Physician Inclusion criteria:

1) Eligible physicians will be the patient's primary attending or his/her designee. If an enrolled patient is cared for by more than one attending physician during their ICU stay, each will be consented.

Physician Exclusion Criteria:

1) Study investigators will be excluded as participants.

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill Intensive Care Unit Patients
• Physician-Family Communication in Intensive Care Units
• Surrogate Decision-making for Critically Ill Patients

Intervention

Behavioral:
• Four Supports Intervention
The Four Supports Intervention is a multi-faceted intervention involving the addition of a trained nurse/social worker interventionist to the patient's care team who delivers four kinds of support: emotional support, communication support, decision support, and anticipatory grief support.
• Educational Control Intervention
In addition to usual care, enrolled surrogates will receive two 15-minute education sessions about critical illness and mechanical ventilation on days 2 and 5, delivered by a research staff coordinator with education in critical care nursing.

Locations

Country	Name	City	State
United States	University of Pittsburgh	Pittsburgh	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pittsburgh	National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Concordance between clinicians and surrogates about patient's prognosis (CSCS)	Prognostic estimates of survival and long-term functional impairment are measured responses by assessing the surrogate decision maker and the physician	Participants are followed at time of enrollment, on day 5 of enrollment, and weekly thereafter for the duration of the hospital stay, an expected average of 4 weeks
Other	Decisional Conflict Scale (DCS)	This validated instrument measures personal perceptions of: uncertainty in choosing options; modifiable factors contributing to uncertainty such as feeling uniformed, unclear about personal values and unsupported in decision making; and; effective decision making such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice.	Participants are followed at time of enrollment and on day 5 of enrollment
Other	Quality of Communication Scale	Quality of communication in family members is assessed using the validated 19 item Quality of Communication Scale	Day 5 of enrollment
Other	Impact of Events Scale	Symptoms of post traumatic stress in family members assessed using the validated 22 item Impact of Events Scale.	at 3 months
Other	Inventory of Complicated Grief	This validated instrument consists of 19 first-person statements concerning the immediate bereavement-related thoughts and behaviors of the participant.	At 3 months and at 6 months
Other	Utilization of Mental Health Treatment	The utilization of mental health treatment is tracked via participant interview	At 3 months and 6 months
Other	Activity of Daily Living	Functional status of the patient is assessed using the validated Katz Activities of Daily Living Scale.	At 6 months
Other	Vital Status	Mortality of the patient will be assessed at 6 months using hospital administrative records, and the 6-month follow-up with surrogate decision makers.	At 6 months
Other	Discharge Dispensation	The disposition of the patient at time of discharge will be assessed via chart abstraction	Participants will be followed for duration of hospital stay, an expected average of 4 weeks
Other	HADS	Hospital Anxiety and Depression Scale	at 3 months
Primary	Hospital Anxiety and Depression Scale	Burden of anxiety and depression will be measured in family members 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).	participants will be followed six months following the patient's death or discharge from hospital, an expected average of 195 days
Secondary	Patient and family-centeredness of care	Patient and family-centeredness of care measured using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted to use by surrogates.	At 6 months
Secondary	Total Hospital Costs	he costs are measured using aggregate data form the date of hospital admission through hospital discharge	Duration of hospital stay, an expected average of 4 weeks
Secondary	Intensive Care Unit Length of Stay	The Intensive Care Unit length of stay , assessed by abstraction from hospital administrative records	Participants will be followed for duration of ICU stay, an expected average of 21 days
Secondary	Hospital Length of stay	Hospital length of stay length of stay , assessed by abstraction from hospital administrative records	Participants will be followed for duration of hospital stay, an expected average of 4 weeks
Secondary	Impact of Events scale at 6 months	Symptoms of post traumatic stress in family members assessed using the validated 22 item Impact of Events Scale.	at 6 months